Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings (vol 14, e0222658, 2019)Lisa A. de Jong,Jessie Groeneveld,Jelena Stevanovic,Harrie Rila,Robert G. Tieleman,Menno V. Huisman,Maarten J. Postma,Marinus van HulstPLOS ONE(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要